RE: RNS - Mr Moulding buys shares!24 Feb 2026 10:49
Let's not forget there is a lot of outside interest in many of THG's assets, and that now Matt has his shares he can drop an RNS at any time
From Q3 transcript, Matt Moulding said:
Look, as you would expect, since we’ve announced the sale of Claremont, there’s obviously a lot of interest in the background as to some of our other manufacturing assets in particular and the performances of that. It would be fair to say we’ve had formal approaches on some of those assets. We’re pretty clear as to how we stand on these things, which is the private market valuations, as we saw with Claremont, are robust. If we receive interest in an asset where we believe we can make a deal work for us without in any way negatively impacting the existing business models of either nutrition or beauty, then sure, we will entertain that and know and derive a fair valuation for one of those assets, especially if it’s of a material value.
If it’s something that’s like with Claremont, it was £100 million plus consideration, then sure, we would do that, especially given the valuations that are on, you know, of THG and the wider PLC market today. I think that’s probably as deep as I should go into that. I think we’ve been pretty frank and open to say, look, we could quite readily put an RNS out at any point to say we’ve done a transaction. It would be something that’s relatively non-core at a fair market value that delivers something that we’re pretty pleased with. How long will that be before we do that? Who knows? It will depend on achieving the right price points, if those prices arrive. That’s probably as much as I can say right now.
Sign In
Follow the stocks
